124 related articles for article (PubMed ID: 6976063)
1. Quantitation of complement C3b and C3d surface receptors on neoplastic IgM positive B lymphocytes.
Jønsson V; Christensen BE; Videbaek A
Acta Pathol Microbiol Scand C; 1981 Aug; 89(4):269-74. PubMed ID: 6976063
[TBL] [Abstract][Full Text] [Related]
2. Distribution of complement receptor subtypes in non-Hodgkin's lymphomas of B-cell origin.
Cossman J; Jaffe ES
Blood; 1981 Jul; 58(1):20-6. PubMed ID: 6972240
[TBL] [Abstract][Full Text] [Related]
3. Use of solid-phase radioimmunoassay specific for human IgG or human C3b to detect Fc gamma or C3b receptors on human lymphoblastoid cell surfaces.
Frade R; Barel M; Charriaut C
Methods Enzymol; 1983; 93():155-63. PubMed ID: 6223196
[No Abstract] [Full Text] [Related]
4. Complement receptors (C3b, C4b/C3d) unbalance on CLL lymphocytes.
Perussia B; Casali P; Joppolo G; Borzini P
Boll Ist Sieroter Milan; 1976 Jul; 55(3):235-40. PubMed ID: 1087884
[TBL] [Abstract][Full Text] [Related]
5. Demonstration of immunoglobulin production by tumor cells in non-Hodgkin's and Hodgkin's malignant lymphomas and its significance for their classification.
Stein H; Papadimitriou CS; Bouman H; Lennert K; Fuchs J
Recent Results Cancer Res; 1978; 64():158-75. PubMed ID: 366694
[TBL] [Abstract][Full Text] [Related]
6. Binding of soluble immune complexes to human lymphoblastoid cells. I. Characterization of receptors for IgG Fc and complement and description of the binding mechanism.
Theofilopoulos AN; Dixon FJ; Bokisch VA
J Exp Med; 1974 Oct; 140(4):877-94. PubMed ID: 4139225
[TBL] [Abstract][Full Text] [Related]
7. Structure and functions of gp 140, the C3d/EBV receptor (CR2) of human B lymphocytes.
Frade R
Mol Immunol; 1986 Nov; 23(11):1249-53. PubMed ID: 2950318
[TBL] [Abstract][Full Text] [Related]
8. Specificity of human lymphocyte complement receptors.
Ross GD; Polley MJ
J Exp Med; 1975 May; 141(5):1163-80. PubMed ID: 805205
[TBL] [Abstract][Full Text] [Related]
9. Distribution of complement receptors on human normal and malignant mononuclear cells.
Slease RB; Gadek JE; Frank MM; Scher I
Blood; 1980 Nov; 56(5):792-7. PubMed ID: 7000204
[TBL] [Abstract][Full Text] [Related]
10. A simple solid phase radioimmunoassay specific for human C3b to detect C3b receptors on human lymphoblastoid cell surfaces.
Barel M; Charriaut C; Frade R
Int Arch Allergy Appl Immunol; 1983; 71(1):1-5. PubMed ID: 6219958
[TBL] [Abstract][Full Text] [Related]
11. A comparative evaluation of receptor reactivities for C3b, iC3b, and C3d on Raji lymphoblastoid cells.
Scheiner O; Hammann KP; Schmid HU; Schulz T; Alsenz J; Dierich MP
Int Arch Allergy Appl Immunol; 1982; 69(3):231-7. PubMed ID: 6215359
[TBL] [Abstract][Full Text] [Related]
12. C3 receptors on human lymphocyte subsets and recruitment of ADCC effector cells by C3 fragments.
Wåhlin B; Perlmann H; Perlmann P; Schreiber RD; Müller-Eberhard HJ
J Immunol; 1983 Jun; 130(6):2831-6. PubMed ID: 6222118
[TBL] [Abstract][Full Text] [Related]
13. Surface phenotyping, histology and the nature of non-Hodgkin lymphoma in 157 patients.
Habeshaw JA; Catley PF; Stansfeld AG; Brearley RL
Br J Cancer; 1979 Jul; 40(1):11-34. PubMed ID: 314300
[TBL] [Abstract][Full Text] [Related]
14. Identification of a C3bi-specific membrane complement receptor that is expressed on lymphocytes, monocytes, neutrophils, and erythrocytes.
Ross GD; Lambris JD
J Exp Med; 1982 Jan; 155(1):96-110. PubMed ID: 6915077
[TBL] [Abstract][Full Text] [Related]
15. Defective complement activity in chronic lymphocytic leukemia.
Heath ME; Cheson BD
Am J Hematol; 1985 May; 19(1):63-73. PubMed ID: 3845763
[TBL] [Abstract][Full Text] [Related]
16. Relationship between different cell surface markers in chronic lymphocytic leukemia.
Potomski J; Harłozińska A; Becker M; Noworolska A
Neoplasma; 1980; 27(3):295-300. PubMed ID: 7453849
[TBL] [Abstract][Full Text] [Related]
17. Mitogenic stimulation of malignant B cells CLL: diminished in-vitro stimulation with anti-CR1 antibodies.
Bloem AC; Chand MA; Daha MR; Bast BJ; Ballieux RE
Leuk Res; 1988; 12(2):109-11. PubMed ID: 2965778
[TBL] [Abstract][Full Text] [Related]
18. Isolation of lymphocyte membrane complement receptor type two (the C3d receptor) and preparation of receptor-specific antibody.
Lambris JD; Dobson NJ; Ross GD
Proc Natl Acad Sci U S A; 1981 Mar; 78(3):1828-32. PubMed ID: 6101236
[TBL] [Abstract][Full Text] [Related]
19. Comparison of peripheral blood lymphocyte C3 receptor capping properties in patients with chronic lymphocytic leukemia and lymphoma.
Hendrick AM; Gormus BJ; Leech SH
Cancer; 1985 Oct; 56(7):1538-42. PubMed ID: 4027890
[TBL] [Abstract][Full Text] [Related]
20. p69,71 antigen complex detected by monoclonal antibody Leu 1 in the identification of particular stages of malignant B-cell differentiation.
Herrmann F; Komischke B; Langermann HJ; Ludwig WD; Sieber G; Rühl H
Scand J Haematol; 1984 Feb; 32(2):215-22. PubMed ID: 6230712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
